Global Urinalysis Market Assessment, By Product [Instruments, Consumables], By Application [Urinary Tract Infections, Diabetes, Pregnancy, Kidney Disease, Others], By End-user [Hospitals, Home Healthcare, Clinical Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F
Global urinalysis market to be driven by the growing prevalence of kidney-related diseases, increasing focus on preventive healthcare, and key product launches.
Home>Industry Reports>Global Urinalysis Market Assessment, Opportunities and Forecast, 2017-2031F
Global urinalysis market is projected to witness a CAGR of 5.77% during the forecast period 2024-2031, growing from USD 4.11 billion in 2023 to USD 6.44 billion in 2031.
The significant expansion of the global urinalysis market stems from various driving forces, such as growing demand for at-home testing, collaborative endeavors among major companies, favorable technological advancements, emphasis on preventive healthcare, and a rise in chronic ailments, especially among aging demographics.
There is a rising inclination toward at-home urinalysis devices, driven by the public's preference for self-care and tailored health management. These user-friendly tools enable independent health monitoring, facilitating early identification and handling of potential health issues. Partnerships between key industry players stimulate joint innovation, combining expertise, resources, and technological prowess. Such partnerships foster the advancement of sophisticated urinalysis solutions, broadening the global urinalysis market presence and enriching product offerings. Continuous advancements, notably in artificial intelligence (AI), automation, and portable devices, transform the landscape of urinalysis. These advancements notably enhance diagnostic processes' speed, precision, and convenience, thereby empowering both healthcare providers and individuals.
Healthcare trends increasingly focus on preventive measures, encouraging the adoption and development of urinalysis tools for early disease detection. Proactive health monitoring aligns with the aim of preventing illnesses before they escalate. The upsurge in chronic illnesses, combined with a globally aging population, drives the necessity for frequent urinalysis. With age-related health concerns rising, the demand intensifies for efficient and precise diagnostic instruments, propelling the expansion of the global urinalysis market. These interconnected elements collectively propel the dynamic growth of the global urinalysis market, molding it to cater to the evolving healthcare requisites of individuals and communities worldwide.
Increasing Focus on Preventive Healthcare
The growing emphasis on preventive healthcare significantly drives the expansion of the global urinalysis market. This focus stimulates the creation and application of urinalysis solutions for early disease detection. Urinalysis plays a crucial role in preventive healthcare by identifying potential health issues, enabling swift interventions, and halting disease progression. With healthcare models prioritizing prevention, there's an increased demand for precise urinalysis tools. This heightened demand solidifies their importance, establishing them as vital components in advancing worldwide healthcare strategies focused on proactive health management. Urinalysis contributes to the transition from reactive to proactive healthcare, fostering an ethos of early detection and intervention to enhance global health outcomes.
Technological Advancements
Technological advancements, particularly AI, are vital in driving the global urinalysis market. AI's incorporation brings about a revolution in urinalysis by significantly improving the accuracy, efficiency, and speed of analyzing and interpreting test results. By employing machine learning (ML) algorithms, AI rapidly recognizes patterns, irregularities, and potential health markers present in urine samples. This innovative technology streamlines diagnostic procedures, enabling faster and more precise identification of diseases or ailments. AI's capacity to learn and adapt enhances diagnostic capabilities, fostering a transition towards more tailored and efficient healthcare solutions. Its integration is pivotal in advancing urinalysis, amplifying its influence within global healthcare frameworks.
For example, in September 2022, the Israeli medical device startup Olive Diagnostics introduced a urinalysis equipment driven by artificial intelligence. The flagship product from Olive Diagnostics, Olive KG, is the first AI- and spectroscopy-based gadget in the world. It provides high-quality analysis of significant parameters in the patient's urine during each urination in a completely passive manner and doesn't require any further attachments.
Growing Popularity of Automated Urine Sediment Analyzer
The increasing adoption of automated urine sediment analyzers significantly boosts the global urinalysis market. These sophisticated systems streamline urine sample analysis by automating sediment examination, leading to heightened precision, speed, and effectiveness in identifying irregularities, thus facilitating faster and more accurate diagnoses. Furthermore, automation minimizes manual errors and labor-intensive processes, elevating reliability and throughput. This surge in usage mirrors the healthcare sector's amplified need for swift, precise, and consistent urinalysis, establishing automated urine sediment analyzers as crucial drivers behind the market's growth.
For instance, the world's first smart toilet clip-on device that would aid in the early diagnosis of health concerns was revealed by the wellness application Vivoo in January 2023. Launched at CES 2023 in Las Vegas, the smart toilet clip-on device can be added to current toilets and includes a urine strip in its seat. The risk of mess that can arise from handheld urine strips is eliminated when the strip automatically moves to align with the user's urine stream.
Growing Demand for At-home Devices
The increasing desire for at-home urinalysis devices is a significant driving force behind the global urinalysis market. These compact tools align with the growing trend of personalized healthcare, granting individuals the convenience of self-monitoring. Offering ease, precision, and instant insights, these devices empower users to oversee diverse health indicators within their home environment. Advancements in technology ensure accessible and prompt results, promoting proactive health maintenance. The rising inclination toward self-tracking and preventive healthcare further emphasizes the necessity for at-home urinalysis devices, establishing them as pivotal contributors to expanding the global urinalysis market.
For example, in January 2023, the medical device company Starling Medical announced the debut of StarStream, an at-home urine diagnostic patient monitoring platform. In contrast to traditional collection receptacles or dipsticks, StarStream examines the urine sample immediately.
Future Market Scenario (2024-2031F)
The future of the global urinalysis market looks promising, driven by several key factors. Technological advancements in AI and automation continually refine and improve urinalysis capabilities, enhancing diagnostic precision and efficiency. Growing demand for at-home testing devices and the emphasis on preventive healthcare further boost the growth of the global urinalysis market, meeting the demand for convenient proactive health monitoring solutions. Collaborations among industry leaders foster innovation, facilitating the development of sophisticated urinalysis tools. With an aging population and a rise in chronic conditions, the necessity for reliable and rapid diagnostic methods intensifies, strengthening the market's potential. These factors position the global urinalysis market for sustained expansion, addressing evolving healthcare needs and propelling advancements in diagnostic technologies worldwide for enhanced healthcare outcomes.
Report Scope
“Urinalysis Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global urinalysis market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 5.77% between 2024-2031 |
|
Revenue Forecast in 2031 |
USD 6.44 billion |
|
Segments Covered |
Product, Application, End-user |
|
Regions Covered |
North America, South America, Europe, Asia-Pacific, Middle East and Africa |
|
F. Hoffmann-La Roche Ltd., Danaher Corporation, Cardinal Health, Inc., Sysmex Corporation, Quidel Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., EKF Diagnostics, Becton, Dickinson and Company |
|
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global urinalysis market has been segmented into the following categories:
o Instruments
§ Automated Urine Sediment Analyzer
§ Biochemical Urine Analyzer
o Consumables
§ Reagents
§ Dipsticks
§ Disposables
· By Application
o Urinary Tract Infections (UTI)
o Diabetes
o Pregnancy
o Kidney Disease
o Others
· By End-user
o Hospitals
o Home Healthcare
o Clinical Laboratories
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
Large corporations in the global urinalysis market are progressively choosing to collaborate, merging their strengths. Through this union, these firms combine resources, research capabilities, and knowledge, nurturing innovation and broadening market reach. Such joint endeavors frequently result in the creation of state-of-the-art diagnostic technologies, innovative testing approaches, and improved product ranges. These partnerships also ease entry into new markets, stimulating growth and competitiveness. Ultimately, these collaborations cultivate a synergy that enables companies to better address evolving healthcare demands, delivering advanced urinalysis solutions on a global scale in a more comprehensive and efficient manner.
For example, in May 2023, Boehringer announced its partnership with Healthy.io to develop the first at-home, smartphone-based diagnostic tool, known as Minuteful Kidney Test, for screening individuals for chronic kidney disease (CKD). The traditional albumin-to-creatinine ratio (ACR) test, which finds protein in the urine and may indicate kidney disease at earlier stages, can be performed using the Minuteful Kidney test.
Key Players Operating in the Global Urinalysis Market are:
· F. Hoffmann-La Roche Ltd.
· Danaher Corporation
· Cardinal Health, Inc.
· Sysmex Corporation
· Quidel Corporation
· Siemens Healthineers AG
· Thermo Fisher Scientific Inc.
· Abbott Laboratories
· Bio-Rad Laboratories, Inc.
· EKF Diagnostics
· Becton, Dickinson and Company
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global urinalysis market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Urinalysis Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.Value
4.1.2.Volume
4.2. By Product
4.2.1.Instruments
4.2.1.1. Automated Urine Sediment Analyzer
4.2.1.2. Biochemical Urine Analyzer
4.2.2.Consumables
4.2.2.1. Reagents
4.2.2.2. Dipsticks
4.2.2.3. Disposables
4.3. By Application
4.3.1.Urinary Tract Infections (UTI)
4.3.2.Diabetes
4.3.3.Pregnancy
4.3.4.Kidney Disease
4.3.5.Others
4.4. By End-user
4.4.1.Hospitals
4.4.2.Home Healthcare
4.4.3.Clinical Laboratories
4.4.4.Others
4.5. By Region
4.5.1.North America
4.5.2.Europe
4.5.3.South America
4.5.4.Asia-Pacific
4.5.5.Middle East and Africa
4.6. By Company Market Share (%), 2023
5. Global Urinalysis Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. Value
5.1.1.2. Volume
5.1.2.By Product
5.1.2.1. Instruments
5.1.2.1.1. Automated Urine Sediment Analyzer
5.1.2.1.2. Biochemical Urine Analyzer
5.1.2.2. Consumables
5.1.2.2.1. Reagents
5.1.2.2.2. Dipsticks
5.1.2.2.3. Disposables
5.1.3.By Application
5.1.3.1.1. Urinary Tract Infections (UTI)
5.1.3.1.2. Diabetes
5.1.3.1.3. Pregnancy
5.1.3.1.4. Kidney Disease
5.1.3.1.5. Others
5.1.4.By End-user
5.1.4.1.1. Hospitals
5.1.4.1.2. Home Healthcare
5.1.4.1.3. Clinical Laboratories
5.1.4.1.4. Others
5.1.5.United States*
5.1.5.1. Market Size & Forecast
5.1.5.1.1. Value
5.1.5.1.2. Volume
5.1.5.2. By Product
5.1.5.2.1. Instruments
5.1.5.2.1.1. Automated Urine Sediment Analyzer
5.1.5.2.1.2. Biochemical Urine Analyzer
5.1.5.2.2. Consumables
5.1.5.2.2.1. Reagents
5.1.5.2.2.2. Dipsticks
5.1.5.2.2.3. Disposables
5.1.5.3. By Application
5.1.5.3.1. Urinary Tract Infections (UTI)
5.1.5.3.2. Diabetes
5.1.5.3.3. Pregnancy
5.1.5.3.4. Kidney Disease
5.1.5.3.5. Others
5.1.5.4. By End-user
5.1.5.4.1. Hospitals
5.1.5.4.2. Home Healthcare
5.1.5.4.3. Clinical Laboratories
5.1.5.4.4. Others
5.1.6.Canada
5.1.7.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Products
6.2. By Application
6.3. By End-user
6.4. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts, Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Danaher Corporation
13.3. Cardinal Health, Inc.
13.4. Sysmex Corporation
13.5. Quidel Corporation
13.6. Siemens Healthineers AG
13.7. Thermo Fisher Scientific Inc.
13.8. Abbott Laboratories
13.9. Bio-Rad Laboratories, Inc.
13.10. EKF Diagnostics
13.11. Becton, Dickinson and Company
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 3. Global Urinalysis Market Share (%), By Product, 2017-2031F
Figure 4. Global Urinalysis Market Share (%), By Application, 2017-2031F
Figure 5. Global Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 6. Global Urinalysis Market Share (%), By Region, 2017-2031F
Figure 7. North America Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 9. North America Urinalysis Market Share (%), By Product, 2017-2031F
Figure 10. North America Urinalysis Market Share (%), By Application, 2017-2031F
Figure 11. North America Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 12. North America Urinalysis Market Share (%), By Country, 2017-2031F
Figure 13. United States Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 15. United States Urinalysis Market Share (%), By Product, 2017-2031F
Figure 16. United States Urinalysis Market Share (%), By Application, 2017-2031F
Figure 17. United States Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 20. Canada Urinalysis Market Share (%), By Product, 2017-2031F
Figure 21. Canada Urinalysis Market Share (%), By Application, 2017-2031F
Figure 22. Canada Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 25. Mexico Urinalysis Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Urinalysis Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 30. Europe Urinalysis Market Share (%), By Product, 2017-2031F
Figure 31. Europe Urinalysis Market Share (%), By Application, 2017-2031F
Figure 32. Europe Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Urinalysis Market Share (%), By Country, 2017-2031F
Figure 34. Germany Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 36. Germany Urinalysis Market Share (%), By Product, 2017-2031F
Figure 37. Germany Urinalysis Market Share (%), By Application, 2017-2031F
Figure 38. Germany Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 39. France Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 41. France Urinalysis Market Share (%), By Product, 2017-2031F
Figure 42. France Urinalysis Market Share (%), By Application, 2017-2031F
Figure 43. France Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 46. Italy Urinalysis Market Share (%), By Product, 2017-2031F
Figure 47. Italy Urinalysis Market Share (%), By Application, 2017-2031F
Figure 48. Italy Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 51. United Kingdom Urinalysis Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Urinalysis Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 56. Russia Urinalysis Market Share (%), By Product, 2017-2031F
Figure 57. Russia Urinalysis Market Share (%), By Application, 2017-2031F
Figure 58. Russia Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 61. Netherlands Urinalysis Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Urinalysis Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 66. Spain Urinalysis Market Share (%), By Product, 2017-2031F
Figure 67. Spain Urinalysis Market Share (%), By Application, 2017-2031F
Figure 68. Spain Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 71. Turkey Urinalysis Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Urinalysis Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 76. Poland Urinalysis Market Share (%), By Product, 2017-2031F
Figure 77. Poland Urinalysis Market Share (%), By Application, 2017-2031F
Figure 78. Poland Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 79. South America Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 81. South America Urinalysis Market Share (%), By Product, 2017-2031F
Figure 82. South America Urinalysis Market Share (%), By Application, 2017-2031F
Figure 83. South America Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 84. South America Urinalysis Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 87. Brazil Urinalysis Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Urinalysis Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 92. Argentina Urinalysis Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Urinalysis Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 97. Asia-Pacific Urinalysis Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Urinalysis Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Urinalysis Market Share (%), By Country, 2017-2031F
Figure 101. India Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 103. India Urinalysis Market Share (%), By Product, 2017-2031F
Figure 104. India Urinalysis Market Share (%), By Application, 2017-2031F
Figure 105. India Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 106. China Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 108. China Urinalysis Market Share (%), By Product, 2017-2031F
Figure 109. China Urinalysis Market Share (%), By Application, 2017-2031F
Figure 110. China Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 113. Japan Urinalysis Market Share (%), By Product, 2017-2031F
Figure 114. Japan Urinalysis Market Share (%), By Application, 2017-2031F
Figure 115. Japan Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 118. Australia Urinalysis Market Share (%), By Product, 2017-2031F
Figure 119. Australia Urinalysis Market Share (%), By Application, 2017-2031F
Figure 120. Australia Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 123. Vietnam Urinalysis Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Urinalysis Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 128. South Korea Urinalysis Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Urinalysis Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 133. Indonesia Urinalysis Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Urinalysis Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 138. Philippines Urinalysis Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Urinalysis Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 143. Middle East & Africa Urinalysis Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Urinalysis Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Urinalysis Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 149. Saudi Arabia Urinalysis Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Urinalysis Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 154. UAE Urinalysis Market Share (%), By Product, 2017-2031F
Figure 155. UAE Urinalysis Market Share (%), By Application, 2017-2031F
Figure 156. UAE Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
Figure 159. South Africa Urinalysis Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Urinalysis Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Urinalysis Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
Who are the key players operating in the global urinalysis market?
What are the major factors influencing the growth of the global urinalysis market?
What are the regions covered in the final report for global urinalysis market?
What is the market size and growth rate of the global urinalysis market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
